Olson, Cheryl K.
Sherwood, Neil
Berkane, Maia
Gilligan, Karin
McKinney, Willie J. Jr.
Article History
Received: 29 March 2022
Accepted: 30 August 2023
First Online: 13 September 2023
Declarations
:
: We followed practices Department of Health and Human Services regulations found at 45 CFR 46.101(b)(2) that exempts research involving survey procedures if information is not recorded in a manner that subjects can be identified (directly or through identifiers linked to the subjects), and if there is no reasonable risk (financial, criminal, civil, employability or reputational) if any subject’s responses were to be disclosed outside the research. The Qualtrics panel online survey participants were recruited from double-opt-in panels (requesting to participate in studies and reconfirmed); no personal identifying information (such as name, age, birthdate or address) was collected by Voccii or shared with the research team. Subjects who had used the product had opted into a customer database, where they were offered an opportunity to participate in the study product purchaser survey via emails from Voccii, with no personal identifying information collected, kept or shared.
: Not applicable.
: CO has received consulting fees from companies to provide summaries of or advice on behavioral science research, including JUUL and Altria. NS has received consulting fees from a number of companies to provide advice and manage projects relating to tobacco product regulatory science. MB has received consulting fees from financial companies to validate their risk models. MB has family ties with one of the LUCY shareholders. KG has received consulting fees from a number of companies to manage projects relating to U.S. FDA applications. WM has received consulting fees from companies in various industries for advice on product regulatory science programs that determine product risks and support U.S. FDA applications.